ESC 365 - Understanding the mechanisms of SGLT2 inhibition in heart failure and diabetes.

HFA Premium Access

Understanding the mechanisms of SGLT2 inhibition in heart failure and diabetes.

Session: Contemporary management of a patient with heart failure and diabetes: implications from recent trials

Topic: Diabetes and the Heart

Speaker: Professor N. Sattar (Glasgow, GB)

Sponsored by Physicians Academy for Cardiovascular Education

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Naveed Sattar

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

43 presentations

7 followers

4 more presentations in this session

Introduction - A patient with Type 2 Diabetes Mellitus (T2DM) in the heart failure clinic.

Speaker: Professor A. Voors (Groningen, NL)

Current management of heart failure & T2DM.

Speaker: Professor M. Cowie (Cambridge, GB)

Guidance from outcome trials: what are the clinical implications?

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Panel discussion.

Speaker: Professor A. Voors (Groningen, NL) Professor M. Cowie (Cambridge, GB)

Access the full session

Contemporary management of a patient with heart failure and diabetes: implications from recent trials

Speakers: Professor N. Sattar, Professor A. Voors, Professor M. Cowie, Professor F. Zannad, Professor A. Voors...

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources